LeMaitre graft recall gets FDA's highest warning

July 24, 2013 by Arezu Sarvestani

The FDA puts its highest-risk label on a recall of LeMaitre Vascular's Albograft vascular graft.

LeMaitre graft recall gets FDA's highest warning

The FDA put its highest-risk Class I label on a recall issued by LeMaitre Vascular (NSDQ:LMAT) over leakage concerns for the Albograft vascular grafts.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp